This low penetrance of the phenotype among patients with this genotype, coupled with undeniable association of the at-risk APOL1 genotype with renal disease, suggests the need for a “second hit” as well as a likely role for other genetic or environmental factors. Here, APOL1 is linked to kidney disorder.